Toronto Dominion Bank’s Starling Oncology, Inc. Warrant STLNW Stock Holding History
Bought
Maintained
Sold
Other funds holding STLNW
OMC
LP
DM
DKCM
WAM
AGM
TCM
CS
Toronto Dominion Bank's STLNW Position: Q1 2026 in Review
Toronto Dominion Bank increased its Starling Oncology, Inc. Warrant (STLNW) stake by 0.11% in Q1 2026, buying an estimated $19 and bringing the position to 187,674 shares worth $8.26K. The position accounts for ﹤0.01% of the portfolio, ranked #1945.
Toronto Dominion Bank first reported a position in STLNW in Q2 2025 and has held it in 4 quarters since. The position peaked at $22.5K in Q3 2025. 11 funds tracked by Wall St. Rank hold STLNW as of Q1 2026.
- Toronto Dominion Bank held 187,674 shares of Starling Oncology, Inc. Warrant worth $8.26K as of Q1 2026.
- Toronto Dominion Bank bought 200 Starling Oncology, Inc. Warrant shares in Q1 2026, an estimated $19.
- Starling Oncology, Inc. Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1945 holding.
- Toronto Dominion Bank first reported a position in Starling Oncology, Inc. Warrant in Q2 2025 and has held it in 4 quarters since.
- Toronto Dominion Bank's Starling Oncology, Inc. Warrant position peaked at $22.5K in Q3 2025.
- 11 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.